The extracellular matrix in diabetic nephropathy - PubMed (original) (raw)
Review
The extracellular matrix in diabetic nephropathy
F N Ziyadeh. Am J Kidney Dis. 1993 Nov.
Free article
Abstract
In the subgroup of diabetic patients who are destined to develop the full spectrum of the clinical syndrome of diabetic nephropathy, the kidney is afflicted with a series of distinct structural lesions principally involving the extracellular matrices. Diabetic nephropathy is characterized by hypertrophy of both glomerular and tubular elements, progressive accumulation of extracellular matrix components in the glomerular mesangium, and thickening of the glomerular and tubular basement membranes. Albeit less well recognized, progressive tubulointerstitial fibrosis is also a feature of the syndrome. Irrespective of pathogenetic mechanisms (be they metabolic, hemodynamic, or genetic), the structural changes involving the renal extracellular matrix compartments are believed to be the basis for the appearance of overt dysfunction, namely, proteinuria, hypertension, and renal failure. Therefore, a full understanding of the mechanisms that culminate in irreversible kidney failure requires a closer inspection of the status of the extracellular matrix in diabetes. This review outlines the different structural changes that typically occur during the course of the disease. Both glomerular and tubulointerstitial changes are reviewed. Valuable structural-functional correlations have been derived from examining kidney specimens obtained from patients with a wide spectrum of disease stages. Experimental animal models, supplanted with recent investigations in tissue culture on the effect of high ambient glucose levels, have increased our understanding of the cellular mechanisms that underlie the disordered matrix composition. Alterations in the metabolism of the collagens, proteoglycans, and other matrix constituents are reviewed.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
Wang SN, LaPage J, Hirschberg R. Wang SN, et al. Kidney Int. 2000 Mar;57(3):1002-14. doi: 10.1046/j.1523-1755.2000.00928.x. Kidney Int. 2000. PMID: 10720953 - The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy.
Chen S, Hong SW, Iglesias-de la Cruz MC, Isono M, Casaretto A, Ziyadeh FN. Chen S, et al. Ren Fail. 2001 May-Jul;23(3-4):471-81. doi: 10.1081/jdi-100104730. Ren Fail. 2001. PMID: 11499562 Review. - Renal tubular basement membrane and collagen type IV in diabetes mellitus.
Ziyadeh FN. Ziyadeh FN. Kidney Int. 1993 Jan;43(1):114-20. doi: 10.1038/ki.1993.19. Kidney Int. 1993. PMID: 8433550 Review. - Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane.
van der Pijl JW, Daha MR, van den Born J, Verhagen NA, Lemkes HH, Bucala R, Berden JH, Zwinderman AH, Bruijn JA, van Es LA, van der Woude FJ. van der Pijl JW, et al. Diabetologia. 1998 Jul;41(7):791-8. doi: 10.1007/s001250050989. Diabetologia. 1998. PMID: 9686920 - Nodular lesions and mesangiolysis in diabetic nephropathy.
Wada T, Shimizu M, Yokoyama H, Iwata Y, Sakai Y, Kaneko S, Furuichi K. Wada T, et al. Clin Exp Nephrol. 2013 Feb;17(1):3-9. doi: 10.1007/s10157-012-0711-6. Epub 2012 Oct 26. Clin Exp Nephrol. 2013. PMID: 23100177 Review.
Cited by
- Proinsulin C-peptide antagonizes the profibrotic effects of TGF-beta1 via up-regulation of retinoic acid and HGF-related signaling pathways.
Hills CE, Willars GB, Brunskill NJ. Hills CE, et al. Mol Endocrinol. 2010 Apr;24(4):822-31. doi: 10.1210/me.2009-0391. Epub 2010 Mar 2. Mol Endocrinol. 2010. PMID: 20197308 Free PMC article. - Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1.
Poczatek MH, Hugo C, Darley-Usmar V, Murphy-Ullrich JE. Poczatek MH, et al. Am J Pathol. 2000 Oct;157(4):1353-63. doi: 10.1016/s0002-9440(10)64649-4. Am J Pathol. 2000. PMID: 11021838 Free PMC article. - TGF-beta: a crucial component of the pathogenesis of diabetic nephropathy.
Goldfarb S, Ziyadeh FN. Goldfarb S, et al. Trans Am Clin Climatol Assoc. 2001;112:27-32; discussion 33. Trans Am Clin Climatol Assoc. 2001. PMID: 11413780 Free PMC article. Review. - RAGE mRNA expression in the diabetic mouse kidney.
Ziyadeh FN, Cohen MP, Guo J, Jin Y. Ziyadeh FN, et al. Mol Cell Biochem. 1997 May;170(1-2):147-52. doi: 10.1023/a:1006857520122. Mol Cell Biochem. 1997. PMID: 9144329 - Transforming growth factor-β-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy.
Deshpande SD, Putta S, Wang M, Lai JY, Bitzer M, Nelson RG, Lanting LL, Kato M, Natarajan R. Deshpande SD, et al. Diabetes. 2013 Sep;62(9):3151-62. doi: 10.2337/db13-0305. Epub 2013 May 6. Diabetes. 2013. PMID: 23649518 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical